Can We Tame the Monster?
"Drug companies should not be allowed to evaluate their own products."
"Drug companies should not be allowed to evaluate their own products."
Yesterday we forwarded an article about Tylenol-linked liver damage published by Associated Press. https://ahrp.org/cms/content/view/278/28/
Below two recent reports by Counterpunch.
Agence France Presse reports that suicide rates in Russia have decreased. Not surprisingly the highest suicide rate in Russia is in Siberia.
Overreliance on toxic drugs is killing healthy people. And the FDA has done next to nothing to prevent drug-induced harm.
BBC reports: "TeGenero, a German pharmaceutical company, said it could not continue in business.Because of the fallout from the UK trial, it was impossible to attract investment, TeGenero said."
Reuters reports that a controlled double-blind trial testing Omega-3 Fatty acids in 28 depressed children (aged 6 to 12) found a positive treatment corrolation.
For almost two decades Eli Lilly has denied that evidence exists demonstrating that its antidepressant Prozac induced violence and suicidality.
In a historic and precedent-setting decision, the Alaska Supreme Court affirmed that the forced administration of psychotropic drugs to patients is unconstitutional!!! : http://psychrights.org/States/Alaska/CaseOne/MyersOpinion.pdf
Compare and contrast two recent news reports about TeenScreen: Lidia Wasowicz of United Press International provides readers with a sense of the controversy generated by psychiatry’s latest market expansion scheme.
The FDA appears to have learned nothing from recent catastrophic disasters.
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
Medical journals are supposed to be vehicles for scientific give and take–not so, evidently, in journals of the American Psychiatric Association.